QNRX: Quoin Pharmaceuticals Ltd
N/A
QNRX Performance Snapshot
1-Week Chg
1-Month Chg
3-Month Chg
6-Month Chg
1-Year Chg
Year-To-Date Chg
Beta 1-Year
-Beta 5-Year
-Volatility (10-Day)
-QNRX Technical Snapshot
QNRX Financial Snapshot
(USD)
2025 Q1
Y/Y CHANGE
Cash and equivalents
$3.82M
108.46%Total assets
$12.96M
-19.65%Total liabilities
$7.03M
0.45%Total investments
$7.73M
-39.87%Shareholders' equity
$5.93M
-35.06%Book value per share
$5.76
132.51%
(USD)
2025 Q1
Y/Y CHANGE
Revenue
$0
0%Net income
-$3.81M
-63.80%Operating expense
$3.96M
60.97%Gross profit
$0
0%EBITDA
-$3.79M
-64.50%Earnings per share
-
-
(USD)
2025 Q1
Y/Y CHANGE
Net change in cash
$198.78K
135.02%Cash from operations
-$2.59M
-80.86%Cash from investing
$2.77M
162.03%Cash from financing
$22.96K
-99.57%Free cash flow
-$2.59M
-80.86%Free cash flow per share
-$2.52
-547.81%
(USD)
2025 Q1
Y/Y CHANGE
Market capitalization
$4.61M
31.63%Enterprise value
$985.82K
-10.42%Shares outstanding
20.59M
458.49%Profit margin
-
-Gross margin
-
-EBITDA margin
-
-
(USD)
2025 Q1
Y/Y CHANGE
Dividend yield
0%
0%Dividends per share
$0
0%Dividend growth
-
-Payout ratio
-
-Coverage ratio
-
-Current ratio
2.57
-28.78%
